Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3319255 | Seminars in Colon and Rectal Surgery | 2015 | 5 Pages |
Abstract
Squamous cell cancer of the anal canal continues to be a rare cancer. Recently, the incidence has been slowly rising in part due to longer-term HIV survivors and in part due to high prevalence of HPV. Early detection and treatment in these high-risk groups is imperative to increasing the survival of the disease. Chemoradiation remains the standard of care for primary therapy, reserving surgical resection for salvage.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Shawn MD,